Zacks Research Issues Negative Outlook for MTD Earnings

Mettler-Toledo International, Inc. (NYSE:MTD) – Stock analysts at Zacks Research lowered their Q4 2025 earnings per share (EPS) estimates for Mettler-Toledo International in a report issued on Friday, October 24th. Zacks Research analyst Team now forecasts that the medical instruments supplier will post earnings of $13.10 per share for the quarter, down from their prior estimate of $13.23. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $42.71 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q1 2027 earnings at $9.63 EPS, Q3 2027 earnings at $12.74 EPS and FY2027 earnings at $51.67 EPS.

MTD has been the subject of a number of other research reports. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Bank of America raised their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th. Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,336.50.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,405.39 on Monday. The firm has a market cap of $28.95 billion, a price-to-earnings ratio of 35.59, a price-to-earnings-growth ratio of 4.27 and a beta of 1.37. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,454.68. The firm’s 50 day moving average price is $1,300.97 and its two-hundred day moving average price is $1,214.73.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the business earned $9.65 earnings per share. The business’s revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds have recently bought and sold shares of MTD. Bank of New York Mellon Corp raised its position in Mettler-Toledo International by 71.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after buying an additional 376,419 shares during the last quarter. Norges Bank bought a new stake in shares of Mettler-Toledo International during the 2nd quarter valued at about $360,126,000. Alliancebernstein L.P. grew its stake in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after purchasing an additional 126,147 shares during the period. PineStone Asset Management Inc. grew its stake in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after purchasing an additional 98,737 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Mettler-Toledo International by 42.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock valued at $361,030,000 after purchasing an additional 90,395 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the business’s stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider owned 94 shares of the company’s stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares of the company’s stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is owned by insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.